Fidarestat
Fidarestat (SNK 860) is an inhibitor of aldose reductase, with IC50s of 26 nM, 33 μM, and 1.8 μM for aldose reductase, AKR1B10 and V301L AKR1B10, respectively; Fidarestat (SNK 860) has the potential to treat diabetic disease.
Product Specifications
CAS Number
136087-85-9
Product Name Alternative
SNK 860
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Aldose Reductase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/Fidarestat.html
Purity
99.63
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
O=C1NC(N[C@@]12C3=C(C=CC(F)=C3)O[C@H](C(N)=O)C2)=O
Molecular Formula
C12H10FN3O4
Molecular Weight
279.23
Precautions
H302, H315, H319, H335
References & Citations
[1]Ruiz FX, et al. X-ray structure of the V301L aldo-keto reductase 1B10 complexed with NADP (+) and the potent aldose reductase inhibitor fidarestat: implications for inhibitor binding and selectivity. Chem Biol Interact. 2013 Feb 25;202 (1-3) :178-85.|[2]Hotta N, et al. Effect of an aldose reductase inhibitor, SNK-860, on deficits in the electroretinogram of diabetic rats. Exp Physiol. 1995 Nov;80 (6) :981-9.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LC426693 20 µg
FLIP (CFLAR) (NM_001127183) Human Over-expression Lysate
Sign In for Pricing
View Details 
